Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Nostrum Biodiscovery logo — One step ahead in molecular design

Nostrum Biodiscovery

One step ahead in molecular design

Founded 2016 Spain Spain 46 employees Seed Total: $710.00K Biotechnology

General Information

Company Name Nostrum Biodiscovery
Founded Year 2016
Location Spain Spain
Employees 46
Industries Biotechnology
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Licensing, Project Based, Subscription
Offices as of Nov 2026
08029 Barcelona, Spain 02142 Cambridge, United States
Social

BounceWatch is an independent company data service, not affiliated with Nostrum Biodiscovery. To contact Nostrum Biodiscovery, visit nostrumbiodiscovery.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nostrum Biodiscovery compare?

A PDF of Nostrum Biodiscovery and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nostrum Biodiscovery soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 20, 2026

Nostrum Biodiscovery participated in The World Vaccine Congress Europe in Amsterdam.

Nostrum Biodiscovery a competitor of yours? Have our desk watch it

About Nostrum Biodiscovery

Nostrum Biodiscovery, founded in 2015, is a biotech spin-off from the prestigious Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB). The company operates at the forefront of Molecular Modelling, providing specialized solutions in therapeutics—like small molecules design and targeted protein degradation—and bio-based chemistry, including enzyme engineering.

The firm leverages a blend of proprietary and third-party software with advanced AI methodologies to deliver customer-tailored solutions that enhance data augmentation and perfect machine-learning algorithms. Committed to innovation and accessibility, Nostrum Biodiscovery is scaling its global footprint, currently serving clients in over 13 countries and actively expanding across Asia, Latin America, the US, and Europe.

No recent external investment details are disclosed, with the last noted being a grant in November 2017. Investors should note the potential in the company's expanding global reach and their cutting-edge approach to biotech solutions.

Business keywords: Molecular Modeling, Therapeutics, Small Molecule Design, Targeted Protein Degradation, Antibodies, Immunologics, Nucleic Acids Design, Enzyme Engineering, Bio-based Chemistry, Drug Discovery, Protein Engineering, Data Augmentation, Machine Learning Algorithms, AI in Biomedical Research

Services & Products

Molecular design and optimization
Drug discovery and development
Protein and nucleic acid engineering
Software licensing and co-development
Research and development collaborations

Target Customers

Biopharmaceutical companies Research institutions Biotech startups Academic researchers Chemical and life sciences industries

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed -
01 Nov 2017
Seed €210.00K 1
CDTI Innvierte
01 Jan 2017
Seed $500.00K 1
The Group Ventures
The Group Ventures
01 Sep 2016
Spinout Undisclosed 5
University Ventures
University Ventures, IRB Barcelona - Institute for Research in Biomedicine +3
01 Dec 2015

Nostrum Biodiscovery Alternatives & Competitors

View All Alternatives
Nostrum Biodiscovery vs
Celeris Therapeutics
Celeris Therapeutics United States

The PIC Engineering Company.

Venture round
1 employees
AI, Biotechnology
Nostrum Biodiscovery vs
SyntheX
SyntheX United States

Targeting the undruggable with synthetic biology-based drug discovery platforms

Venture round
26 employees
Biotechnology, Health and Wellness
Nostrum Biodiscovery vs
Nurix Therapeutics
Nurix Therapeutics United States

Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outma...

IPO
378 employees
Biotechnology
Also compare with: Nostrum Biodiscovery vs Galux Galux View all alternatives

FAQ About Nostrum Biodiscovery

One step ahead in molecular design
Nostrum Biodiscovery was founded in 2016.
Nostrum Biodiscovery is headquartered in Spain. As of Nov 2026, it also has offices in 08029 Barcelona, Spain and 02142 Cambridge, United States.
Nostrum Biodiscovery operates in Biotechnology. Its work centres on Molecular Modeling, Therapeutics, Small Molecule Design and Targeted Protein Degradation. Its customers include Biopharmaceutical companies, Research institutions and Biotech startups.
Nostrum Biodiscovery has a B2B, SaaS and Platform business model. Its revenue comes from Licensing, Project Based and Subscription.
Nostrum Biodiscovery has approximately 46 employees.
Nostrum Biodiscovery has completed 4 funding rounds, raising a total of $710.00K. The latest funding stage is Seed.
Nostrum Biodiscovery offers: Molecular design and optimization, Drug discovery and development, Protein and nucleic acid engineering, Software licensing and co-development, Research and development collaborations.
Top alternatives and competitors to Nostrum Biodiscovery include Celeris Therapeutics, SyntheX, Nurix Therapeutics, Degron Therapeutics, C4 Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nostrum Biodiscovery and Celeris Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nostrum Biodiscovery, https://bouncewatch.com/company/nostrum-biodiscovery, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout